Research and Markets: Global Migraine Report 2014: Zecuity Forecast and Market Analysis to 2023


Research and Markets ( has announced the addition of the “Zecuity (Migraine) – Forecast and Market Analysis to 2023″ report to their offering.

Zecuity is the first and only skin patch approved to deliver sumatriptan in patients needing acute treatment to abort their migraines and migraine-related nausea. Zecuity uses a proprietary SmartRelief technology which uses a mild electric current to transport sumatriptan across the skin, a process called iontophoresis. It uses an electric current to pull ionized drug particles through the skin while monitoring the skin’s resistance to the transfer of sumatriptan during the four-hour dosing.


  • Overview of Migraine, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
  • Detailed information on Zecuity including product description, safety and efficacy profiles as well as a SWOT analysis.
  • Sales forecast for Zecuity for the US from 2012 to 2023.
  • Sales information covered for the US.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Disease Overview

4 Disease Management

5 Competitive Assessment

6 Opportunity and Unmet Need

7 Pipeline Assessment

8 Zecuity

9 Appendix

For more information visit

  • Personal Investing Ideas & Strategies
  • Health

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Did you find this useful? More Info:


    Download your FREE Report on Headache


    Just a sneak peek…

    • Guide to cluster headache
    • Why do you get a headache?
    • Headache and migraine pain relief through hypnotherapy
    • Can stress cause severe headache?
    • Caffeine: the culprit behind our migraines
    • Menopause and headaches
    • Sinusitis: how serious is it?
    Download It Completely FREE

    Just Insert Your Name and email

    We will also send you a Complimentary copy of our Headache Newsletter. Our newsletter subscription has the latest information on Headache and Migraine treatments.

    We respect your privacy. We will NEVER sell, rent or share your email address. That’s more than a policy, it’s our personal guarantee!

  • Now you can have the Latest News on Headache


    Worried about Headache and Migraine? You can have now information about the latest treatments and medical research. All this and more in our Headache Newsletter.slide11t

    Try it for four weeks. We will even send you FREE our bonus health e-book with your trial subscription.

    All for just ONE PENNY

    Get the latest information – don’t be left in the dark on your condition.


    Check our special offer: Subscribe to one newsletter, get another newsletter for FREE!